Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib

Vivian E. M. van den Boogaart; Quido G. de Lussanet; Ruud M. A. Houben; Dirk de Ruysscher; Harry J. M. Groen; J. Tim Marcus; Egbert F. Smit; Anne-Marie C. Dingemans; Walter H. Backes

doi:https://doi.org/10.1016/j.lungcan.2015.12.009

Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib

Vivian E. M. van den Boogaart, Quido G. de Lussanet, Ruud M. A. Houben, Dirk de Ruysscher, Harry J. M. Groen, J. Tim Marcus, Egbert F. Smit, Anne-Marie C. Dingemans, Walter H. Backes

Pulmonary medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	20-27
Journal	Lung Cancer
Volume	93
DOIs	https://doi.org/10.1016/j.lungcan.2015.12.009
Publication status	Published - Mar 2016

Keywords

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)
non-small cell lung cancer
response assessment
targeted therapy
validity and reproducibility

Access to Document

https://doi.org/10.1016/j.lungcan.2015.12.009

Cite this

van den Boogaart, V. E. M., de Lussanet, Q. G., Houben, R. M. A., de Ruysscher, D., Groen, H. J. M., Marcus, J. T., Smit, E. F., Dingemans, A.-M. C., & Backes, W. H. (2016). Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib. Lung Cancer, 93, 20-27. https://doi.org/10.1016/j.lungcan.2015.12.009

@article{6d474dd807fe4a1eae3869322bf19902,

title = "Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib",

keywords = "Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), non-small cell lung cancer, response assessment, targeted therapy, validity and reproducibility",

author = "{van den Boogaart}, {Vivian E. M.} and {de Lussanet}, {Quido G.} and Houben, {Ruud M. A.} and {de Ruysscher}, Dirk and Groen, {Harry J. M.} and Marcus, {J. Tim} and Smit, {Egbert F.} and Dingemans, {Anne-Marie C.} and Backes, {Walter H.}",

year = "2016",

month = mar,

doi = "https://doi.org/10.1016/j.lungcan.2015.12.009",

language = "English",

volume = "93",

pages = "20--27",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

}

van den Boogaart, VEM, de Lussanet, QG, Houben, RMA, de Ruysscher, D, Groen, HJM, Marcus, JT, Smit, EF, Dingemans, A-MC & Backes, WH 2016, 'Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib', Lung Cancer, vol. 93, pp. 20-27. https://doi.org/10.1016/j.lungcan.2015.12.009

Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib. / van den Boogaart, Vivian E. M.; de Lussanet, Quido G.; Houben, Ruud M. A. et al.
In: Lung Cancer, Vol. 93, 03.2016, p. 20-27.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib

AU - van den Boogaart, Vivian E. M.

AU - de Lussanet, Quido G.

AU - Houben, Ruud M. A.

AU - de Ruysscher, Dirk

AU - Groen, Harry J. M.

AU - Marcus, J. Tim

AU - Smit, Egbert F.

AU - Dingemans, Anne-Marie C.

AU - Backes, Walter H.

PY - 2016/3

Y1 - 2016/3

KW - Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)

KW - non-small cell lung cancer

KW - response assessment

KW - targeted therapy

KW - validity and reproducibility

U2 - https://doi.org/10.1016/j.lungcan.2015.12.009

DO - https://doi.org/10.1016/j.lungcan.2015.12.009

M3 - Article

C2 - 26898610

SN - 0169-5002

VL - 93

SP - 20

EP - 27

JO - Lung Cancer

JF - Lung Cancer

ER -